Description
Sacituzumab tirumotecan versus treatment of physician’s
choice in previously treated endometrial cancer
(TroFuse-005/ENGOT-en23/GOG-3095): a randomised,
open-label, phase 3 trial
Read the full article here:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02099-4/fulltext?dgcid=youtube_video_lancet_tl_esmo_short
* * *
Continue this conversation on social! Follow us today at…
https://bsky.app/profile/thelancet.com
https://Facebook.com/TheLancetMedicalJournal
https://Instagram.com/TheLancetGroup
https://LinkedIn.com/company/The-Lancet